PUBLISHED-SEQUENCE ANTIBODY · SC-PSA-0404

Plutavimab antibody

SARS-CoV-2 spike receptor-binding domain

Available by inquiry

Plutavimab is a research antibody reference targeting SARS-CoV-2 spike receptor-binding domain. Pure and fluorescently conjugated formats are available by inquiry.

Catalog number
SC-PSA-0404
Target
SARS-CoV-2 spike receptor-binding domain
Available formats
Pure or fluorescently conjugated
Research use
For research use only

Product information

Available labeling options

Pure · Biotin · BV421 · V450 · V500 · AF488 · PerCP-Cy5.5 · PE · AF594 · PE-Cy5 · PE-Cy7 · APC · AF700 · APC-Cy7

Tell us the intended application, amount and preferred label. Final configuration and delivery are confirmed in the quotation.

PUBLIC REFERENCE

Reference source

WHO Recommended INN List 88 (2022)

View reference ↗
START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact us
Plutavimab Antibody (SARS-CoV-2 spike receptor-binding domain) | StellaCyte